Idenix Pharmaceuticals ^Corporations

Idenix Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of drugs for the treatment of human viral diseases. Their main research and development focus is on the treatment of hepatitis C virus (HCV), but they have also developed products and drug candidates for the treatment of hepatitis B virus (HBV), human immunodeficiency virus type I (HIV), and acquired immune deficiency syndrome (AIDS). They have completed proof-of-concept clinical trials and initiated phase IIa clinical trials for their drug candidates. With operations in the United States and Europe, Idenix Pharmaceuticals is dedicated to finding innovative solutions for viral diseases.